Press Release: Innora GmbH and WeMed Technologies Forge Strategic Partnership
Berlin, September 30, 2024 — Innora GmbH and WeMed Technologies are pleased to announce that they have entered into a strategic partnership aimed at bringing innovations to the field of peripheral vascular devices. This collaboration will focus on developing a Drug Transfer Balloon Catheter System (DTB) for targeted drug delivery within the vasculature.
Through this partnership, Innora GmbH will provide its expertise and resources to support the development of WeMed Technologies’ DTB system. The shared goal is to create a next-generation medical device that enables more effective treatment of vascular diseases and meets the evolving needs of the healthcare sector.
Dr. Thomas Speck, CEO of Innora GmbH, stated, "This collaboration represents a significant step in advancing targeted drug delivery technology for vascular treatments." Ahmet Alnidelik, Founder and CEO of WeMed Technologies, added, "This partnership will accelerate the development process of our DTB system and help us bring this innovative device to market more efficiently."
We plan to announce the initial results of the project within the coming year.